Moreover, gelatinases A and B (MMP-2 and MMP-9) constitute risk factors for myocardial infarction [58] whereas their tissue inhibitors TIMPs have an impact on postmyocardial infarction remodelling [59], [60] and correlate positively with left ventricular mass and wall thickness [61]. This evidence concerns the gene MMP9 and infarction.